CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Scientific Officer sold 2,043 shares at an average $3.69 ($7,546)
- 4 Open-market sale Chief Financial Officer sold 2,946 shares at an average $3.69 ($10,885)
- 4 Open-market sale Chief Development Officer sold 2,043 shares at an average $3.69 ($7,545)
- 4 Open-market sale Chief Manufacturing Officer sold 2,995 shares at an average $3.69 ($11,061)
- 4 Open-market sale Chief People Officer sold 2,535 shares at an average $3.70 ($9,367)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Financial Officer sold 2,525 shares at an average $4.31 ($10,886)
- 4 Open-market sale Chief Scientific Officer sold 1,751 shares at an average $4.31 ($7,543)
- 4 Open-market sale Chief Development Officer sold 1,732 shares at an average $4.30 ($7,455)
- 4 Open-market sale Chief Manufacturing Officer sold 2,536 shares at an average $4.31 ($10,928)
- 4 Open-market sale Chief People Officer sold 2,175 shares at an average $4.31 ($9,369)
- 4 Open-market sale Chief Development Officer sold 844 shares at $4.33 ($3,655)
- 4 Open-market sale Chief Manufacturing Officer sold 1,261 shares at $4.33 ($5,461)
- 4 Open-market sale Chief Scientific Officer sold 863 shares at $4.33 ($3,738)
- 4 Open-market sale Chief Financial Officer sold 1,347 shares at $4.33 ($5,834)
- 4 Open-market sale Chief People Officer sold 1,168 shares at $4.33 ($5,059)
- 4 Exercise or conversion President and CEO acquired 6,905 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 6,905 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 6,905 shares (option exercise)
Page 11 of 18 · 354 filings